Uric acid and risk of heart failure: a systematic review and meta-analysis (Q26852555)

Baotao Huang

2

1 reference

Yulin Li

3

1 reference

Yan Huang

4

1 reference

Jing Li

5

1 reference

Hongmei Yao

6

1 reference

Xianchao Jing

7

1 reference

Jianrong Chen

8

1 reference

Ji Wang

9

1 reference

language of work or name

1 reference

January 2014

1 reference

European Journal of Heart Failure

published in

1 reference

volume

16

1 reference

issue

1

1 reference

page(s)

15-24

1 reference

Hyperuricaemia does not impair cardiovascular function in healthy adults

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Uric acid and long-term outcomes in CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Hyperuricemia and incident hypertension: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Hyperuricemia and incident heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Hyperhomocysteinemia in patients with symptomatic chronic heart failure: prevalence and prognostic importance--pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

The profile and prognosis of patients hospitalised with heart failure. The value of discharge blood pressure amd cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Multidisciplinary management of elderly patients with chronic heart failure: five year outcome measures in death and survivor groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Uric Acid as prognostic marker in advanced nonischemic dilated cardiomyopathy: comparison with N-terminal pro B-type natriuretic peptide level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Routine Laboratory Results and Thirty Day and One-Year Mortality Risk Following Hospitalization with Acute Decompensated Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

The independent impact of congestive heart failure status and diuretic use on serum uric acid among men with a high cardiovascular risk profile: a prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

7 January 2021

Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

7 January 2021

Uric acid in CHF: marker or player in a metabolic disease?

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

7 January 2021

Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

7 January 2021

Hyperuricemia predicts adverse outcomes in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

7 January 2021

Predictors of clinical outcomes in elderly patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

7 January 2021

Can meta-analysis be salvaged?

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

7 January 2021

Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

7 January 2021

Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

7 January 2021

Serum Uric Acid and Risk of Cardiovascular Mortality: A Prospective Long-Term Study of 83 683 Austrian Men

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

7 January 2021

Publication Bias: A Problem in Interpreting Medical Data

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT132

7 January 2021